It’s been almost a year since the Food and Drug Administration approved the first genetic treatments for sickle cell disease.

GC Therapeutics has entered gameplay with the mission of unlocking a new generation of cell therapies, uploading with $75 ...

The Cell & Gene Therapy manufacturing Services market is driven by increasing investments in advanced therapies, rising ...

Mice treated with the gene therapy remained cancer-free for at least 100 days and resisted cancer resurgence in a lab test.

A newly developed gene therapy shows great potential for treating glaucoma, a condition that can lead to vision loss.

ROCKVILLE, Md. and SOUTH SAN FRANCISCO, Calif., Sept. 15, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, ...

Ori Biotech (Ori), a leader in cell and gene therapy (CGT) manufacturing enabling technology, and Charles River Laboratories (Charles River), a global industry-leading drug discovery, preclinical ...

The researchers took what they said was a conservative approach when plugging variables such as one-time and future costs ...

Scientists from Trinity College Dublin have developed a highly promising gene therapy to treat glaucoma, a debilitating eye ...

Research successes are driving gene therapy for inherited deafness to the clinic, but commercialization efforts are needed to ...

Co-expressing NPY and its inhibitory receptor Y2 in excitatory hippocampal cells allows inhibitory autoregulation of ...